These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 25048802)
1. A subset of circulating blood mycobacteria-specific CD4 T cells can predict the time to Mycobacterium tuberculosis sputum culture conversion. Riou C; Gray CM; Lugongolo M; Gwala T; Kiravu A; Deniso P; Stewart-Isherwood L; Omar SV; Grobusch MP; Coetzee G; Conradie F; Ismail N; Kaplan G; Fallows D PLoS One; 2014; 9(7):e102178. PubMed ID: 25048802 [TBL] [Abstract][Full Text] [Related]
2. Frequency of Circulating CD4 Ferrian S; Ross M; Conradie F; Vally Omar S; Ismail N; Little F; Kaplan G; Fallows D; Gray CM Front Immunol; 2018; 9():2438. PubMed ID: 30410488 [TBL] [Abstract][Full Text] [Related]
3. Phenotypic Changes on Mycobacterium Tuberculosis-Specific CD4 T Cells as Surrogate Markers for Tuberculosis Treatment Efficacy. Ahmed MIM; Ntinginya NE; Kibiki G; Mtafya BA; Semvua H; Mpagama S; Mtabho C; Saathoff E; Held K; Loose R; Kroidl I; Chachage M; von Both U; Haule A; Mekota AM; Boeree MJ; Gillespie SH; Hoelscher M; Heinrich N; Geldmacher C Front Immunol; 2018; 9():2247. PubMed ID: 30323818 [No Abstract] [Full Text] [Related]
5. Tuberculosis Therapy Modifies the Cytokine Profile, Maturation State, and Expression of Inhibitory Molecules on Mycobacterium tuberculosis-Specific CD4+ T-Cells. Saharia KK; Petrovas C; Ferrando-Martinez S; Leal M; Luque R; Ive P; Luetkemeyer A; Havlir D; Koup RA PLoS One; 2016; 11(7):e0158262. PubMed ID: 27367521 [TBL] [Abstract][Full Text] [Related]
6. Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response. Adekambi T; Ibegbu CC; Cagle S; Kalokhe AS; Wang YF; Hu Y; Day CL; Ray SM; Rengarajan J J Clin Invest; 2015 May; 125(5):1827-38. PubMed ID: 25822019 [TBL] [Abstract][Full Text] [Related]
7. Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda. Nakiyingi L; Ssengooba W; Nakanjako D; Armstrong D; Holshouser M; Kirenga BJ; Shah M; Mayanja-Kizza H; Joloba ML; Ellner JJ; Dorman SE; Manabe YC BMC Infect Dis; 2015 Feb; 15():62. PubMed ID: 25888317 [TBL] [Abstract][Full Text] [Related]
8. Potent immune responses of Ag-specific Vgamma2Vdelta2+ T cells and CD8+ T cells associated with latent stage of Mycobacterium tuberculosis coinfection in HIV-1-infected humans. Shao L; Zhang W; Zhang S; Chen CY; Jiang W; Xu Y; Meng C; Weng X; Chen ZW AIDS; 2008 Nov; 22(17):2241-50. PubMed ID: 18981763 [TBL] [Abstract][Full Text] [Related]
9. Kinetics of Mycobacterium tuberculosis-specific IFN-γ responses and sputum bacillary clearance in HIV-infected adults during treatment of pulmonary tuberculosis. Mzinza DT; Sloan DJ; Jambo KC; Shani D; Kamdolozi M; Wilkinson KA; Wilkinson RJ; Davies GR; Heyderman RS; Mwandumba HC Tuberculosis (Edinb); 2015 Jul; 95(4):463-9. PubMed ID: 26051653 [TBL] [Abstract][Full Text] [Related]
10. Impact of antiretroviral and tuberculosis therapies on CD4 Chiacchio T; Petruccioli E; Vanini V; Cuzzi G; La Manna MP; Orlando V; Pinnetti C; Sampaolesi A; Antinori A; Caccamo N; Goletti D Immunol Lett; 2018 Jun; 198():33-43. PubMed ID: 29635002 [TBL] [Abstract][Full Text] [Related]
11. Baseline Xpert MTB/RIF ct values predict sputum conversion during the intensive phase of anti-TB treatment in HIV infected patients in Kampala, Uganda: a retrospective study. Namugenyi J; Musaazi J; Katamba A; Kalyango J; Sendaula E; Kambugu A; Fehr J; Castelnouvo B; Manabe YC; Ssengooba W; Sekaggya-Wiltshire C BMC Infect Dis; 2021 Jun; 21(1):513. PubMed ID: 34074248 [TBL] [Abstract][Full Text] [Related]
12. Activation Phenotype of Luo Y; Xue Y; Mao L; Lin Q; Tang G; Song H; Liu W; Tong S; Hou H; Huang M; Ouyang R; Wang F; Sun Z Front Immunol; 2021; 12():721013. PubMed ID: 34512645 [TBL] [Abstract][Full Text] [Related]
13. The role of Kisuya J; Chemtai A; Raballah E; Okumu W; Keter A; Ouma C Pan Afr Med J; 2018; 31():166. PubMed ID: 31086619 [TBL] [Abstract][Full Text] [Related]
16. A CD4+CD161+ T-Cell Subset Present in Unexposed Humans, Not Tb Patients, Are Fast Acting Cells That Inhibit the Growth of Intracellular Mycobacteria Involving CD161 Pathway, Perforin, and IFN-γ/Autophagy. Yang R; Peng Y; Pi J; Liu Y; Yang E; Shen X; Yao L; Shen L; Modlin RL; Shen H; Sha W; Chen ZW Front Immunol; 2021; 12():599641. PubMed ID: 33732233 [TBL] [Abstract][Full Text] [Related]
17. HIV Infection Is Associated With Downregulation of BTLA Expression on Barham MS; Abrahams DA; Khayumbi J; Ongalo J; Tonui J; Campbell A; de Kock M; Ouma SG; Odhiambo FH; Hanekom WA; Gandhi NR; Day CL Front Immunol; 2019; 10():1983. PubMed ID: 31497018 [TBL] [Abstract][Full Text] [Related]
18. The frequencies of IFNγ+IL2+TNFα+ PPD-specific CD4+CD45RO+ T-cells correlate with the magnitude of the QuantiFERON® gold in-tube response in a prospective study of healthy indian adolescents. Jenum S; Grewal HM; Hokey DA; Kenneth J; Vaz M; Doherty TM; Jahnsen FL; PLoS One; 2014; 9(7):e101224. PubMed ID: 24992314 [TBL] [Abstract][Full Text] [Related]
19. Increased Frequency of Memory CD4+ T-Cell Responses in Individuals With Previously Treated Extrapulmonary Tuberculosis. Barreto-Duarte B; Sterling TR; Fiske CT; Almeida A; Nochowicz CH; Smith RM; Barnett L; Warren C; Blackman A; Lapa E Silva JR; Andrade BB; Kalams SA Front Immunol; 2020; 11():605338. PubMed ID: 33391271 [TBL] [Abstract][Full Text] [Related]
20. Correlation of mycobacterium tuberculosis specific and non-specific quantitative Th1 T-cell responses with bacillary load in a high burden setting. Theron G; Peter J; Lenders L; van Zyl-Smit R; Meldau R; Govender U; Dheda K PLoS One; 2012; 7(5):e37436. PubMed ID: 22629395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]